Abstract
Three different inherited disorders are known in which thiamine may exert a beneficial effect: maple syrup urine disease (MSUD), lactic acidaemia and the syndrome of megaloblastic anaemia with sensorineural deafness and diabetes mellitus. The amounts of thiamine which were used for long-term treatment varied from 20 to 2400mg day‒1. Additional treatment, such as the reduction of dietary branched chain amino acids in MSUD, could not be omitted in some cases. It has been shown that the vitamin improves the stability of the branched chain ketoacid decarboxylase, although some weeks may be needed to observe the in vivo effect of treatment. A prolonged trial with high doses of thiamine should always be given.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blass, J. P., Lonsdale, D., Uhlendorf, B. W. and Avigan, J. Intermittent ataxia with pyruvate decarboxylase deficiency. Clin. Res. 18 (1970) 393
Brunette, M. G., Delvin, E., Hazel, B. and Scriver, C. R. Thiamine-responsive lactic acidosis in a patient with deficient low-K m pyruvate carboxylase activity in liver. Pediatrics 50 (1972) 702–711
Chuang, D. T., Ku, L. S. and Cox, R. P. Thiamin-responsive maple syrup urine disease: decreased affinity of the mutant branched-chain α-keto acid dehydrogenase for α-ketoiso-valerate and thiamin pyrophosphate. Proc. Natl. Acad. Sci. USA 79 (1982) 3300–3304
Cooper, J. R., Itokawa, Y. and Pincus, J. H. Thiamine triphosphate deficiency in subacute necrotizing encephalo-myelopathy. Science 164 (1969) 74–75
Danner, D. J., Wheeler, F. B., Lemmon, S. K. and Elsas, L. J. In vivo and in vitro response of human branched chain α-ketoacid dehydrogenase to thiamine and thiamine pyrophosphate. Pediatr. Res. 12 (1978) 235–238
Davis, R. E. and Icke, G. C. Clinical chemistry of thiamine. Adv. Clin. Chem. 23 (1983) 93–140
Duran, M., Tielens, A. G. M., Wadman, S. K., Stigter, J. C. M. and Kleijer, W. J. Effects of thiamine in a patient with a variant form of branched-chain ketoaciduria. Acta Paediatr. Scand. 67 (1978) 367–372
Elsas, L. J. and Danner, D. J. The role of thiamin in maple syrup urine disease. Ann. N.Y. Acad. Sci. 378 (1982) 404–427
Elsas, L. J., Danner, D. J., Lubitz, D., Fernhoff, P. M. and Dembure, P. P. Metabolic consequences of inherited defects in branched chain α-ketoacid dehydrogenase: mechanism of thiamine action. In Walser M. and Williamson, J. P. (eds.) Metabolism and Clinical Implications of Branched Chain Amino and Ketoacids, Elsevier, Amsterdam, 1981, pp. 369–382
Fritsch, G., Langenbeck, U., Wendel, U., Lehnert, W., Palm, W. and Steger, W. Intermittierende Form der Ahornsirupkrankheit bei einem 12 jährigen Knaben: Klinik, Diagnostik und Therapie. Klin Pädiat. 195 (1983) 351–354
Haworth, C., Evans, D. I. K., Mitra, J. and Wickramasinghe, S. N. Thiamine responsive anaemia: study of two further cases. Br. J. Haematol. 50 (1982) 549–561
Heffelfiinger, S. C., Sewell, E. T., Elsas, L. J. and Danner, D. J. Direct physical evidence for stabilization of branched chain α-ketoacid dehydrogenase by thiamin pyrophosphate. Am. J. Hum. Genet. 36 (1984) 802–808
van der Horst, J. L. and Wadman, S. K. A variant form of branched-chain ketoaciduria. Acta Paediatr. Scand. 60 (1971) 594–599
Kodama, S., Seki, A., Hanabusa, M., Morisita, Y., Sakurai, T. and Matsuo, T. Mild variant of maple syrup urine disease. Eur. J. Pediatr. 124 (1976) 31–36
Krawiecki, N., Hartlage, P., Roesel, A., Carter, L. and Hommes, F. A. Thiamine responsive lactacidemia. J. Inher. Metab. Dis. Suppl. 2 (1984) 98 (title only)
Lonsdale, D., Faulkner, W. R., Price, J. W. and Smeby, R. R. Intermittent cerebellar ataxia associated with hyperpyruvic acidemia, hyperalaninemia, and hyperalaninuria. Pediatrics 43 (1969) 1025–1034
Menkes, J. H. Maple syrup urine disease: Isolation and identification of organic acids in the urine. Pediatrics 23 (1959) 348–353
Poggi, V., Longo, G., DeVizia, B., Andria, G., Rindi, G., Patrini, C. and Cassandro, E. Thiamin-responsive megaloblastic anaemia: a disorder of thiamin transport? J. Inher. Metab. Dis. 7, Suppl. 2 (1984) 153–154
Pueschel, S. M., Bresnan, M. J., Shin, V. E. and Levy, H. L. Thiamine-responsive intermittent branched-chain ketoaciduria. J. Pediatr. 94 (1979) 628–631
Rogers, L. E., Stanley-Porter, F. and Sidbury, J. B. Thiamine-responsive megaloblastic anemia. J. Pediatr. 74 (1969) 494–504
Scriver, C. R., MacKenzie, S., Clow, C. L. and Delvin, E. Thiamin responsive maple syrup urine disease. Lancet i (1971)310–311
Smit, G. P. A., le Coultre, R., Fernandes, J., Berger, R. and Begeer, J. H. Reversible symptoms of the central and peripheral nervous system in a patient with pyruvate decarboxylase (E1) deficiency. Abstr. 22nd Symp. SSIEM, Newcastle (1984) 71
Viana, M. B. and Carvalho, R. I. Thiamine-responsive megaloblastic anemia, sensorineural deafness, and diabetes mellitus: a new syndrome? J. Pediatr. 93 (1978) 235–238
Wick, H., Schweizer, K. and Baumgartner, R. Thiamine dependency in a patient with congenital lacticacidaemia due to pyruvate dehydrogenase deficiency. Agents Actions 7 (1977) 405–410
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1985 SSIEM and MTP Press Limited
About this chapter
Cite this chapter
Duran, M., Wadman, S.K. (1985). Thiamine-responsive Inborn Errors of Metabolism. In: Addison, G.M., Bartlett, K., Harkness, R.A., Pollitt, R.J. (eds) Inherited Disorders of Vitamins and Cofactors. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-8019-1_13
Download citation
DOI: https://doi.org/10.1007/978-94-011-8019-1_13
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-8021-4
Online ISBN: 978-94-011-8019-1
eBook Packages: Springer Book Archive